Selected research
Industry Research
Hyaluronic Acid for Ophthalmic Therapy Industry Research Report 2026
Market perspective
The global Hyaluronic Acid for Ophthalmic Therapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hyaluronic Acid for Ophthalmic Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hyaluronic Acid for Ophthalmic Therapy is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hyaluronic Acid for Ophthalmic Therapy is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hyaluronic Acid for Ophthalmic Therapy include Abott, LG Life Sciences, Shandong Mingren Freda Pharmaceutical Co., Ltd., Changzhou Institute of Medicine Co., Ltd., Shanghai Haohai Biological Technology Co., Ltd., Bloomage BioTechnology Corporation Limited and Hang Zhou Singclean Medical Products Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hyaluronic Acid for Ophthalmic Therapy market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hyaluronic Acid for Ophthalmic Therapy Market by Company
Abott
LG Life Sciences
Shandong Mingren Freda Pharmaceutical Co., Ltd.
Changzhou Institute of Medicine Co., Ltd.
Shanghai Haohai Biological Technology Co., Ltd.
Bloomage BioTechnology Corporation Limited
Hang Zhou Singclean Medical Products Co., Ltd.
Hyaluronic Acid for Ophthalmic Therapy Segment by Type
Hyaluronic Acid Viscoelastic
Hyaluronic Acid Artificial Tears
Hyaluronic Acid for Ophthalmic Therapy Segment by Application
Dry Eye Syndrome
Cataract
Others
Hyaluronic Acid for Ophthalmic Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyaluronic Acid for Ophthalmic Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyaluronic Acid for Ophthalmic Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyaluronic Acid for Ophthalmic Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyaluronic Acid for Ophthalmic Therapy manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyaluronic Acid for Ophthalmic Therapy by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyaluronic Acid for Ophthalmic Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hyaluronic Acid Viscoelastic
- Hyaluronic Acid Artificial Tears
Applications
- Dry Eye Syndrome
- Cataract
- Others
Companies covered
- Abott
- LG Life Sciences
- Shandong Mingren Freda Pharmaceutical Co., Ltd.
- Changzhou Institute of Medicine Co., Ltd.
- Shanghai Haohai Biological Technology Co., Ltd.
- Bloomage BioTechnology Corporation Limited
- Hang Zhou Singclean Medical Products Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hyaluronic Acid for Ophthalmic Therapy Market Size (2021-2032)
- 2.2.2 Global Hyaluronic Acid for Ophthalmic Therapy Sales (2021-2032)
- 2.2.3 Global Hyaluronic Acid for Ophthalmic Therapy Market Average Price (2021-2032)
- 2.3 Hyaluronic Acid for Ophthalmic Therapy by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hyaluronic Acid Viscoelastic
- 2.3.3 Hyaluronic Acid Artificial Tears
- 2.4 Hyaluronic Acid for Ophthalmic Therapy by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dry Eye Syndrome
- 2.4.3 Cataract
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hyaluronic Acid for Ophthalmic Therapy Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hyaluronic Acid for Ophthalmic Therapy Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Hyaluronic Acid for Ophthalmic Therapy Revenue of Manufacturers (2021-2026)
- 3.4 Global Hyaluronic Acid for Ophthalmic Therapy Average Price by Manufacturers (2021-2026)
- 3.5 Global Hyaluronic Acid for Ophthalmic Therapy Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hyaluronic Acid for Ophthalmic Therapy, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hyaluronic Acid for Ophthalmic Therapy, Product Type & Application
- 3.8 Global Manufacturers of Hyaluronic Acid for Ophthalmic Therapy, Established Date
- 3.9 Global Hyaluronic Acid for Ophthalmic Therapy Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abott
- 4.1.1 Abott Company Information
- 4.1.2 Abott Business Overview
- 4.1.3 Abott Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abott Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.1.5 Abott Recent Developments
- 4.2 LG Life Sciences
- 4.2.1 LG Life Sciences Company Information
- 4.2.2 LG Life Sciences Business Overview
- 4.2.3 LG Life Sciences Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 LG Life Sciences Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.2.5 LG Life Sciences Recent Developments
- 4.3 Shandong Mingren Freda Pharmaceutical Co., Ltd.
- 4.3.1 Shandong Mingren Freda Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Shandong Mingren Freda Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Shandong Mingren Freda Pharmaceutical Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Mingren Freda Pharmaceutical Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.3.5 Shandong Mingren Freda Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Changzhou Institute of Medicine Co., Ltd.
- 4.4.1 Changzhou Institute of Medicine Co., Ltd. Company Information
- 4.4.2 Changzhou Institute of Medicine Co., Ltd. Business Overview
- 4.4.3 Changzhou Institute of Medicine Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Changzhou Institute of Medicine Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.4.5 Changzhou Institute of Medicine Co., Ltd. Recent Developments
- 4.5 Shanghai Haohai Biological Technology Co., Ltd.
- 4.5.1 Shanghai Haohai Biological Technology Co., Ltd. Company Information
- 4.5.2 Shanghai Haohai Biological Technology Co., Ltd. Business Overview
- 4.5.3 Shanghai Haohai Biological Technology Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Haohai Biological Technology Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.5.5 Shanghai Haohai Biological Technology Co., Ltd. Recent Developments
- 4.6 Bloomage BioTechnology Corporation Limited
- 4.6.1 Bloomage BioTechnology Corporation Limited Company Information
- 4.6.2 Bloomage BioTechnology Corporation Limited Business Overview
- 4.6.3 Bloomage BioTechnology Corporation Limited Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bloomage BioTechnology Corporation Limited Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.6.5 Bloomage BioTechnology Corporation Limited Recent Developments
- 4.7 Hang Zhou Singclean Medical Products Co., Ltd.
- 4.7.1 Hang Zhou Singclean Medical Products Co., Ltd. Company Information
- 4.7.2 Hang Zhou Singclean Medical Products Co., Ltd. Business Overview
- 4.7.3 Hang Zhou Singclean Medical Products Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hang Zhou Singclean Medical Products Co., Ltd. Hyaluronic Acid for Ophthalmic Therapy Product Portfolio
- 4.7.5 Hang Zhou Singclean Medical Products Co., Ltd. Recent Developments
5 Global Hyaluronic Acid for Ophthalmic Therapy Market Scenario by Region
- 5.1 Global Hyaluronic Acid for Ophthalmic Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Region: 2021-2032
- 5.2.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Region: 2021-2026
- 5.2.2 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Region: 2027-2032
- 5.3 Global Hyaluronic Acid for Ophthalmic Therapy Revenue by Region: 2021-2032
- 5.3.1 Global Hyaluronic Acid for Ophthalmic Therapy Revenue by Region: 2021-2026
- 5.3.2 Global Hyaluronic Acid for Ophthalmic Therapy Revenue by Region: 2027-2032
- 5.4 North America Hyaluronic Acid for Ophthalmic Therapy Market Facts & Figures by Country
- 5.4.1 North America Hyaluronic Acid for Ophthalmic Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hyaluronic Acid for Ophthalmic Therapy Sales by Country (2021-2032)
- 5.4.3 North America Hyaluronic Acid for Ophthalmic Therapy Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hyaluronic Acid for Ophthalmic Therapy Market Facts & Figures by Country
- 5.5.1 Europe Hyaluronic Acid for Ophthalmic Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hyaluronic Acid for Ophthalmic Therapy Sales by Country (2021-2032)
- 5.5.3 Europe Hyaluronic Acid for Ophthalmic Therapy Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hyaluronic Acid for Ophthalmic Therapy Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hyaluronic Acid for Ophthalmic Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hyaluronic Acid for Ophthalmic Therapy Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hyaluronic Acid for Ophthalmic Therapy Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hyaluronic Acid for Ophthalmic Therapy Market Facts & Figures by Country
- 5.7.1 South America Hyaluronic Acid for Ophthalmic Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hyaluronic Acid for Ophthalmic Therapy Sales by Country (2021-2032)
- 5.7.3 South America Hyaluronic Acid for Ophthalmic Therapy Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Hyaluronic Acid for Ophthalmic Therapy Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hyaluronic Acid for Ophthalmic Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hyaluronic Acid for Ophthalmic Therapy Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hyaluronic Acid for Ophthalmic Therapy Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Type (2021-2032)
- 6.1.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Hyaluronic Acid for Ophthalmic Therapy Sales Market Share by Type (2021-2032)
- 6.2 Global Hyaluronic Acid for Ophthalmic Therapy Revenue by Type (2021-2032)
- 6.2.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hyaluronic Acid for Ophthalmic Therapy Revenue Market Share by Type (2021-2032)
- 6.3 Global Hyaluronic Acid for Ophthalmic Therapy Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Application (2021-2032)
- 7.1.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Hyaluronic Acid for Ophthalmic Therapy Sales Market Share by Application (2021-2032)
- 7.2 Global Hyaluronic Acid for Ophthalmic Therapy Revenue by Application (2021-2032)
- 7.2.1 Global Hyaluronic Acid for Ophthalmic Therapy Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hyaluronic Acid for Ophthalmic Therapy Revenue Market Share by Application (2021-2032)
- 7.3 Global Hyaluronic Acid for Ophthalmic Therapy Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hyaluronic Acid for Ophthalmic Therapy Value Chain Analysis
- 8.1.1 Hyaluronic Acid for Ophthalmic Therapy Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hyaluronic Acid for Ophthalmic Therapy Production Mode & Process
- 8.2 Hyaluronic Acid for Ophthalmic Therapy Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hyaluronic Acid for Ophthalmic Therapy Distributors
- 8.2.3 Hyaluronic Acid for Ophthalmic Therapy Customers
9 Global Hyaluronic Acid for Ophthalmic Therapy Analyzing Market Dynamics
- 9.1 Hyaluronic Acid for Ophthalmic Therapy Industry Trends
- 9.2 Hyaluronic Acid for Ophthalmic Therapy Industry Drivers
- 9.3 Hyaluronic Acid for Ophthalmic Therapy Industry Opportunities and Challenges
- 9.4 Hyaluronic Acid for Ophthalmic Therapy Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst